Applied Biosystems to invest in VisiGen Biotechnologies Inc.
06-Jan-2006
"Applied Biosystems continues to extensively evaluate potential next-generation sequencing technologies. We believe that the quality of VisiGen's science and the progress towards the development of single-molecule sequencing technology is quite impressive," explained Catherine M. Burzik, President of Applied Biosystems.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.